BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9568058)

  • 1. Focal expression of thymidine phosphorylase associates with CD31 positive lymphocytic aggregation and local neo-angiogenesis in non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Kakolyris S; Kaklamanis L; Barbatis K; O'Byrne KJ; Theodosssiou D; Harris AL; Gatter KC
    Anticancer Res; 1998; 18(1A):71-6. PubMed ID: 9568058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Theodossiou D; Barbatis K; O'Byrne K; Harris AL; Gatter KC
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2485-92. PubMed ID: 9815651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
    O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
    Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Sivridis E; O'Byrne K; Gatter KC; Harris AL
    J Pathol; 2000 Oct; 192(2):140-9. PubMed ID: 11004689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression.
    Kakolyris S; Giatromanolaki A; Koukourakis M; Leigh IM; Georgoulias V; Kanavaros P; Sivridis E; Gatter KC; Harris AL
    Cancer Res; 1999 Nov; 59(21):5602-7. PubMed ID: 10554041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival.
    Koukourakis MI; Giatromanolaki A; Kakolyris S; O'Byrne KJ; Apostolikas N; Skarlatos J; Gatter KC; Harris AL
    Br J Cancer; 1998 May; 77(10):1696-703. PubMed ID: 9635852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
    Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis in gastric cancer: importance of the thymidine phosphorylase expression of cancer cells as an angiogenic factor.
    Han HS; Hwang TS
    Oncol Rep; 2007 Jan; 17(1):61-5. PubMed ID: 17143479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-derived endothelial cell growth factor (thymidine phosphorylase) expression in lung cancer.
    Giatromanolaki A; Koukourakis MI; Comley M; Kaklamanis L; Turley H; O'Byrne K; Harris AL; Gatter KC
    J Pathol; 1997 Feb; 181(2):196-9. PubMed ID: 9120725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
    Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of thymidine phosphorylase correlates with microvessel density in prostate cancer.
    Kataoka A; Yuasa T; Kageyama S; Iwaki H; Higuchi K; Tanaka T; Okada Y; Yoshiki T
    Oncol Rep; 2005 Apr; 13(4):597-600. PubMed ID: 15756429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
    Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M
    Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer.
    van Triest B; Pinedo HM; Blaauwgeers JL; van Diest PJ; Schoenmakers PS; Voorn DA; Smid K; Hoekman K; Hoitsma HF; Peters GJ
    Clin Cancer Res; 2000 Mar; 6(3):1063-72. PubMed ID: 10741735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.
    Koukourakis MI; Giatromanolaki A; Thorpe PE; Brekken RA; Sivridis E; Kakolyris S; Georgoulias V; Gatter KC; Harris AL
    Cancer Res; 2000 Jun; 60(11):3088-95. PubMed ID: 10850461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of tumor angiogenesis and thymidine phosphorylase tissue expression in patients with endometrial cancer.
    Mazurek A; Kuc P; Terlikowski S; Laudanski T
    Neoplasma; 2006; 53(3):242-6. PubMed ID: 16652195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of angiogenesis in non-small cell lung cancer.
    Giatromanolaki A
    Anticancer Res; 2001; 21(6B):4373-82. PubMed ID: 11908693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer.
    Aikawa H; Takahashi H; Fujimura S; Sato M; Endo C; Sakurada A; Kondo T; Tanita T; Matsumura Y; Ono S; Saito Y; Sagawa M
    Anticancer Res; 1999; 19(5B):4305-9. PubMed ID: 10628391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidine phosphorylase expression in tumor-infiltrating macrophages may be correlated with poor prognosis in uterine endometrial cancer.
    Tanaka Y; Kobayashi H; Suzuki M; Kanayama N; Suzuki M; Terao T
    Hum Pathol; 2002 Nov; 33(11):1105-13. PubMed ID: 12454815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of vascular maturation in lung and breast carcinomas using a novel basement membrane component, LH39.
    Kakolyris S; Giatromanolaki A; Koukourakis M; Kaklamanis L; Kouroussis CH; Bozionelou V; Georgoulias V; Gatter KC; Harris AL
    Anticancer Res; 2001; 21(6B):4311-6. PubMed ID: 11908685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase in psoriatic epidermis.
    Creamer D; Jaggar R; Allen M; Bicknell R; Barker J
    Br J Dermatol; 1997 Dec; 137(6):851-5. PubMed ID: 9470899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.